1. Home
  2. ENOV vs ZGN Comparison

ENOV vs ZGN Comparison

Compare ENOV & ZGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • ZGN
  • Stock Information
  • Founded
  • ENOV 1995
  • ZGN 1910
  • Country
  • ENOV United States
  • ZGN Italy
  • Employees
  • ENOV N/A
  • ZGN N/A
  • Industry
  • ENOV Fluid Controls
  • ZGN Apparel
  • Sector
  • ENOV Industrials
  • ZGN Consumer Discretionary
  • Exchange
  • ENOV Nasdaq
  • ZGN Nasdaq
  • Market Cap
  • ENOV 2.1B
  • ZGN 1.9B
  • IPO Year
  • ENOV 2008
  • ZGN N/A
  • Fundamental
  • Price
  • ENOV $36.95
  • ZGN $7.38
  • Analyst Decision
  • ENOV Buy
  • ZGN Buy
  • Analyst Count
  • ENOV 4
  • ZGN 2
  • Target Price
  • ENOV $58.50
  • ZGN $8.05
  • AVG Volume (30 Days)
  • ENOV 849.1K
  • ZGN 942.3K
  • Earning Date
  • ENOV 05-01-2025
  • ZGN 03-27-2025
  • Dividend Yield
  • ENOV N/A
  • ZGN 1.75%
  • EPS Growth
  • ENOV N/A
  • ZGN N/A
  • EPS
  • ENOV N/A
  • ZGN 0.31
  • Revenue
  • ENOV $2,107,623,000.00
  • ZGN $2,015,371,157.00
  • Revenue This Year
  • ENOV $7.09
  • ZGN $4.49
  • Revenue Next Year
  • ENOV $6.38
  • ZGN $5.90
  • P/E Ratio
  • ENOV N/A
  • ZGN $23.76
  • Revenue Growth
  • ENOV 23.45
  • ZGN 2.21
  • 52 Week Low
  • ENOV $34.44
  • ZGN $7.07
  • 52 Week High
  • ENOV $62.79
  • ZGN $14.24
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 38.61
  • ZGN 42.14
  • Support Level
  • ENOV $36.43
  • ZGN $7.23
  • Resistance Level
  • ENOV $38.56
  • ZGN $8.10
  • Average True Range (ATR)
  • ENOV 1.44
  • ZGN 0.27
  • MACD
  • ENOV 0.08
  • ZGN 0.05
  • Stochastic Oscillator
  • ENOV 40.10
  • ZGN 30.10

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About ZGN Ermenegildo Zegna N.V.

Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.

Share on Social Networks: